Capital formation challenges in the industry have forced many biotech companies to halt projects, lay off staff or shutdown all together. Our analysis shows that the industry is approximately one-quarter smaller than it was in 2008.
|
May 10, 2012
|
May 4, 2012
|
May 1, 2012
|
April 27, 2012
|
|
April 26, 2012
|
April 26, 2012
|
April 17, 2012
|
April 13, 2012
|